Brilivog M 500mg/0.2mg Tablet SR

Overview Brilivog M 500mg/0.2mg Tablet SR

Diabeva-M 500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabeva-M 500mg/0.2mg Extended-Release Tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication is one component of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are paramount in diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, flatulence, abdominal discomfort, diarrhea, and skin rashes; these are usually transient and self-limiting. Persistent or concerning side effects warrant medical consultation. Your physician can offer management strategies for troublesome side effects. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function as advised by your doctor.

Primary Ingredients of Brilivog M 500mg/0.2mg Tablet SR

There is no text provided to rephrase.

Uses of Brilivog M 500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Brilivog M 500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Brilivog M 500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Brilivog M 500mg/0.2mg Tablet SR:

• Flatulence
• Diarrhea
• Abdominal pain
• Vomiting
• Decreased appetite

How to use Brilivog M 500mg/0.2mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Brilivog M 500mg/0.2mg Sustained-Release tablets with food.

How Brilivog M 500mg/0.2mg Tablet SR works:

Brilivog M 500mg/0.2mg extended-release tablets contain a dual antidiabetic formulation.

What if you forget to take Brilivog M 500mg/0.2mg Tablet SR :

Should you forget to take a Brilivog M 500mg/0.2mg Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.